Abstract:Ferroptosis is an iron ion-dependent, regulatory cell death modality driven by intracellular lipid peroxidation that plays a key role in the development of HCC. Studies have shown that various clinical agents (e.g., sorafenib) have ferroptosis inducer-like effects and can exert therapeutic effects by modulating different key factors in the ferroptosis pathway. This implies that targeting tumor cell ferroptosis may be a very promising strategy for tumor therapy. In this paper, we summarize the prerequisites and defense systems for the occurrence of ferroptosis and the regulatory targets of drug-mediated ferroptosis action in HCC, the differences and connections between ferroptosis and other programmed cell deaths. We aim to summarize the theoretical basis, classical inducers of ferroptosis and research progress of ferroptosis in HCC cells, clued to the treatment of HCC by regulating ferroptosis network. Further investigation of the specific mechanisms of ferroptosis and the development of hepatocellular carcinoma and interventions at different stages of hepatocellular carcinoma will help us to deepen our understanding of hepatocellular carcinoma, with a view to providing new and more precise preventive as well as therapeutic measures for patients.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of ferroptosis in hepatocellular carcinoma (HCC) and its potential as a new strategy for tumor treatment. Specifically, the paper summarizes the pre - conditions for ferroptosis to occur and the defense system, the regulatory targets of drug - mediated ferroptosis, and the differences and connections between ferroptosis and other programmed cell deaths. The paper also aims to summarize the theoretical basis of ferroptosis, classic inducers and the progress of ferroptosis research in HCC cells, in order to treat HCC by regulating the ferroptosis network. ### Analysis of the Core Problems in the Paper 1. **The role of ferroptosis in the development of HCC**: - Ferroptosis is an iron - ion - dependent, regulatory cell death mode driven by intracellular lipid peroxidation and plays a crucial role in the development of HCC. - Studies have shown that a variety of clinical drugs (such as sorafenib) have effects similar to ferroptosis inducers and can play a therapeutic role by regulating different key factors in the ferroptosis pathway. 2. **The regulatory mechanism of ferroptosis**: - The paper discusses in detail the conditions required for ferroptosis to occur, including how imbalances in lipid metabolism, amino acid metabolism, iron metabolism, glutathione metabolism, etc. affect the degree of ferroptosis in cells. - There are defense mechanisms against ferroptosis in nature, mainly including enzymatic and non - enzymatic antioxidant mechanisms. 3. **The relationship between ferroptosis and other programmed cell deaths**: - There are differences and connections between ferroptosis and other programmed cell death modes such as apoptosis, necroptosis, and pyroptosis. - By comparing these different cell death modes, it is helpful to better understand the occurrence mechanism and unique characteristics of ferroptosis. 4. **The application prospects of ferroptosis in the treatment of HCC**: - Targeting ferroptosis in tumor cells may be a very promising strategy for tumor treatment. - Further research on the specific mechanism of ferroptosis and its role in the development of HCC, and intervention at different stages of HCC will help deepen the understanding of HCC and provide new and more accurate prevention and treatment measures for patients. ### Conclusion The paper emphasizes the important role of ferroptosis in HCC and proposes that precisely targeting tumor cells to induce ferroptosis may become a new way to treat cancer. At the same time, the paper also points out the relationship between ferroptosis and other programmed cell deaths, providing a theoretical basis for further research.

Ferroptosis: a new hunter of hepatocellular carcinoma